Pfizer’s booster shots effective against Omicron variant: Israeli study
Category: #headlines  | By Nikita Chaurasia  | Date: 2021-12-13 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Pfizer’s booster shots effective against Omicron variant: Israeli study

Israeli researchers have reported that three shots of the Pfizer/BioNTech coronavirus vaccine provide considerable protection against the new Omicron variant.

The research was conducted by Central Virology Laboratory of the Health Ministry and Sheba Medical Centre. The study included a blood comparison of 20 people who had taken two vaccine doses 5-6 months earlier to the same number of individuals who had taken a booster shot a month ago.

Director of Sheba’s Infectious Diseases Unit, Gili Regev-Yochay, mentioned that people who had taken the second dose 5-6 months ago did not show any neutralization capacity against the Omicron variant, while they showed some against the Delta strain.

Regev-Yochay added that while the booster dose offers almost a hundred-fold increase in protection, it is still about four times less effective against Omicron as compared to the Delta variant.

The results were much like those presented by Pfizer and BioNTech early this week, which were a primary indication that booster shots could be important in offering protection against infection from the newly identified variant.

The Israeli team stated that it worked with the actual virus while the companies worked with what is known as a pseudo virus, which was bio-engineered to have the characteristic mutations of Omicron. The Israeli research builds on the study from South Africa that discovered that two doses are not effective enough against the new Omicron variant.

Despite reports confirming that the third shot of the Pfizer/BioNTech offering significant protection against Omicron, BioNTech has started working on a vaccine specifically targeting the Omicron variant in late November and could be out with a customized vaccine ready for distribution within 100 days.

Meanwhile, Israel announced restrictions banning its citizens from travelling to Denmark, Britain, and Belgium due to the spread of the new variant.  

The PM Naftali Bennett is reportedly being urged to impose stricter restrictions in Israel over the coming days.

 

Source Credit: https://www.dailymail.co.uk/news/article-10302089/Three-shots-Pfizer-vaccine-DOES-protect-against-Omicron-Israeli-study-shows.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Samsung kickstarts chip production with 3nm process technology

Samsung kickstarts chip production with 3nm process technology

By Nikita Chaurasia

Samsung Electronics Co Ltd has reportedly declared that it has begun the mass production of chips using advanced 3-nanometre technology. The company is the first in the entire world to do so and is actively looking for new clients to contest with Tai...

Progcap nabs $40Mn in funding round for expansion & product development

Progcap nabs $40Mn in funding round for expansion & product development

By Nikita Chaurasia

Progcap, a pioneer in the field of corporate-driven financing solutions for small and medium-sized businesses (SMBs), has secured $40 million in private equity capital at $600 million valuation. The raised capital forms a part of the Series C exte...

Microsoft solidifies Qatar investment; Unveils new high-tech office

Microsoft solidifies Qatar investment; Unveils new high-tech office

By Nikita Chaurasia

Microsoft, the global tech behemoth, has recently stated that it is expanding its operation in Qatar by unveiling a new Lusail City unit, the firm’s largest and fourth in the country. This new facility forms part of a substantial investment tha...